Post Profile

Testimony: Shkreli’s plans to swindle patients is what hooked big investors

In colorful fraud trial, former investors explain why they got involved with Shkreli.
read more


Related Posts

CEO Martin Shkreli fires his legal team in fraud case

Business & Finance : Business Pundit

Former pharmaceuticals CEO and hedge fund manager Martin Shkreli has fired his legal counsel and plans to hire a new legal team to defend him against charges that he defrauded investors at his former hedge fund and a pharmaceutical ...

‘Pharma Bro’ Martin Shkreli fraud trial set for June 2017

News : The Raw Story

Martin Shkreli, the former pharmaceutical executive who last year became a lightning rod for criticism of soaring prescription drug prices, is now scheduled to go on trial in June 2017 in the U.S. government’s securities fraud case ...

‘Pharma Bro’ quits: Martin Shkreli leaves Turing amid charges of swindling investors

News : The Raw Story

Shkreli announced resignation from the company he founded after FBI arrested him Thursday on charges he duped investors in his former hedge fund Pharmaceutical entrepreneur Martin Shkreli has resigned as chief executive of the compa...

Investor says Martin Shkreli reminded him of ‘Rain Man’

News : The Raw Story

An investor in Martin Shkreli’s hedge fund testified on Monday that the former drug company executive, now on trial for securities fraud in federal court in New York, reminded him of Dustin Hoffman’s autistic character in the movie ...

Martin Shkreli trial: Investors describe 'Pharma Bro' as shady — but profitable

Business & Finance : LA Times: Business

The jury at the securities fraud trial of “Pharma Bro” Martin Shkreli has heard investors accuse the quirky former biotech chief executive of repeatedly giving them the runaround when they tried to pull their money out of his failin...


Technology Industry News
Copyright © 2016 Regator, LLC